Table 2 Comparison between joint deterioration in follow-up imaging after core decompression with investigated variables
Radiographic deterioration | Uni-variable logistic regression | Multivariable logistic regression | ||
|---|---|---|---|---|
Odds ratio (CI 95%) | P value | Odds ratio (CI 95%) | P value | |
Male gender | 1.176( 0.068–20.262) | 0.911 |  |  |
Bilateral Hip osteonecrosis | 0.850 (0.163–4.426) | 0.847 | ||
Abnormal C3, C4 levels | 1.400 (0.325–6.027) | 0.651 | ||
Abnormal aPL levels | 12.750 (1.421–14.400) | 0.023* | 10.301 (0.930–14.140) | 0.047* |
SLE relapse | 5.687 (1.378–23.480) | 0.016* | 1.900 (0.241–14.998) | 0.542 |
Kidney damage | 3.143 (0.846–11.671) | 0.087 | 2.001 (0.217 -18.435) | 0.540 |
Neuro damage | 0.526 (0.078–3.565) | 0.511 |  |  |
Azathioprine | 7.000 (1.668–29.384) | 0.008** | ||
HCQ | 0.914 (0.204–4.088) | 0.907 | ||
Methotrexate | 0.219 (0.711–22.505) | 0.116 | ||
Mycophenolate mofetil | 1.176 (0.226–6.127) | 0.847 | ||
Aspirin | 0.308 (0.082–1.149) | 0.08 | 0.327 (0.053–2.024) | 0.229 |
Statins | 0.333 (0.070–1.597) | 0.169 |  |  |
Bisphosphonate | 0.967 (0.265–3.526) | 0.959 | ||
Smoking (Cigarette) | 0.824 (0.174–3.903) | 0.807 | ||
Alcohol | 0.833 (0.146–4.752) | 0.837 | ||
Anti-ds DNA level | With independent sample T test 78.5–111.7 (IU/ml) | 0.09 |  |  |